Alexion is a great growth story MarketWatch Is the stock still a good growth story, and is it currently trading at a reasonable price? By the way, the company is a $14.9 billion drug maker out of Cheshire, CT. They develop therapeutics to treat cancer, autoimmune disorders, transplant rejection, ... |
